Estimating Costs in Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa-Reply.

JAMA Dermatol

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Published: November 2024

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2024.2970DOI Listing

Publication Analysis

Top Keywords

estimating costs
4
costs beremagene
4
beremagene geperpavec
4
geperpavec dystrophic
4
dystrophic epidermolysis
4
epidermolysis bullosa-reply
4
estimating
1
beremagene
1
geperpavec
1
dystrophic
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!